UPDATE 1-Pfizer in talks to merge off-patent drugs business with Mylan -source <!-- no image --> <div>Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter.<div class="feedflare"> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=KZgVC45TQWE:KbZ17FSnSCw:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?d=yIl2AUoC8zA" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=KZgVC45TQWE:KbZ17FSnSCw:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=KZgVC45TQWE:KbZ17FSnSCw:V_sGLiPBpWU" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=KZgVC45TQWE:KbZ17FSnSCw:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=KZgVC45TQWE:KbZ17FSnSCw:F7zBnMyn0Lo" border="0"></a> </div><img src="http://feeds.feedburner.com/~r/reuters/UKBankingFinancial/~4/KZgVC45TQWE" height="1" width="1" alt=""></div> Posted by Reuters